PT  - JOURNAL ARTICLE
AU  - Prado, Elizabeth L.
AU  - Arnold, Charles D.
AU  - Wessells, K. Ryan
AU  - Stewart, Christine P.
AU  - Abbeddou, Souheila
AU  - Adu-Afarwuah, Seth
AU  - Arnold, Benjamin F.
AU  - Ashorn, Ulla
AU  - Ashorn, Per
AU  - Becquey, Elodie
AU  - Brown, Kenneth H.
AU  - Chandna, Jaya
AU  - Christian, Parul
AU  - Dentz, Holly N.
AU  - Dulience, Sherlie J. L.
AU  - Fernald, Lia C. H.
AU  - Galasso, Emanuela
AU  - Hallamaa, Lotta
AU  - Hess, Sonja Y.
AU  - Huybregts, Lieven
AU  - Iannotti, Lora L.
AU  - Jimenez, Elizabeth Yakes
AU  - Kohl, Patricia
AU  - Lartey, Anna
AU  - Port, Agnes Le
AU  - Luby, Stephen P.
AU  - Maleta, Kenneth
AU  - Matchado, Andrew
AU  - Matias, Susana L.
AU  - Mridha, Malay K.
AU  - Ntozini, Robert
AU  - Null, Clair
AU  - Ocansey, Maku E.
AU  - Parvez, Sarker Masud
AU  - Phuka, John
AU  - Pickering, Amy J.
AU  - Prendergast, Andrew J.
AU  - Shamim, Abu Ahmed
AU  - Siddiqui, Zakia
AU  - Tofail, Fahmida
AU  - Weber, Ann M.
AU  - Wu, Lee S. F.
AU  - Dewey, Kathryn G.
TI  - Small-quantity lipid-based nutrient supplements for children age 6-24 months: a systematic review and individual participant data meta-analysis of effects on developmental outcomes and effect modifiers
AID  - 10.1101/2021.02.15.21251423
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.15.21251423
4099  - http://medrxiv.org/content/early/2021/02/18/2021.02.15.21251423.short
4100  - http://medrxiv.org/content/early/2021/02/18/2021.02.15.21251423.full
AB  - Background Small-quantity lipid-based nutrient supplements (SQ-LNS) reduce child stunting and provide many of the fatty acids and micronutrients that are necessary for rapid brain development that occurs during infancy and early childhood. Positive effects of SQ-LNS on developmental outcomes have been found in some trials, but not others.Objectives Our objectives were to generate pooled estimates of the effect of SQ-LNS, compared to control groups that received no intervention or an intervention without any nutritional supplement, on developmental outcomes (language, social-emotional, motor, and executive function), and to identify study-level and individual-level modifiers of these effects.Methods We conducted a two-stage meta-analysis of individual participant data from 14 intervention versus control group comparisons in 13 randomized trials of SQ-LNS provided to infants and young children age 6 to 24 months in 9 low- or middle-income countries (total n=30,024). We generated study-specific estimates of SQ-LNS vs. control groups (including main effects and subgroup estimates for individual-level effect modifiers) and pooled the estimates using fixed-effects models. We used random effects meta-regression to examine potential study-level effect modifiers.Results In 11-13 intervention versus control group comparisons (n=23,588-24,561), SQ-LNS increased mean language (mean difference: 0.07 standard deviations; 95% CI: 0.04, 0.10), social-emotional (0.08; 0.05, 0.11), and motor scores (0.08; 0.05, 0.11) and reduced the prevalence of children in the lowest decile of these scores by 17% (prevalence ratio: 0.83, 95% CI 0.76, 0.91), 19% (0.81; 0.74, 0.90), and 16% (0.84; 0.77, 0.92), respectively. SQ-LNS also increased the prevalence of children walking without support at 12 months by 9% (1.09; 1.05, 1.14). Effects of SQ-LNS on language, social-emotional, and motor outcomes were larger among study populations with a higher burden (≥ 35%) of child stunting at 18 months (mean difference 0.11-0.13 SD; 8-9 comparisons) than in populations with lower stunting burden (estimates near zero). At the individual level, greater effects of SQ-LNS were found on language among children who were acutely malnourished (mean difference: 0.31) at baseline; on language (0.12), motor (0.11), and executive function (0.06) among children in households with lower socio-economic status; and on motor development among later-born children (0.11), children of older mothers (0.10), and children of mothers with lower education (0.11).Conclusions SQ-LNS provided daily to children in the range of 6-24 months of age can be expected to result in modest, but potentially important, developmental gains, particularly in populations with high child stunting burden. Certain groups of children who experience higher risk environments, such as those from poor households or with poor baseline nutritional status, have greater potential to benefit from SQ-LNS in developmental outcomes. This study was registered at www.crd.york.ac.uk/PROSPERO as CRD42020159971.Competing Interest StatementAll authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: KGD, KRW and CDA had financial support from the Bill & Melinda Gates Foundation for the submitted work; KRW and SYH have received research grants from Nutriset, SAS, outside the submitted work; all other co-authors report financial support for the original trials that contributed data to this paper, but not for the work directly related to this analysis; no other relationships or activities that could appear to have influenced the submitted work.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020159971 https://osf.io/ymsfu/ Funding StatementThis publication is based on research funded by a grant to the University of California, Davis from the Bill & Melinda Gates Foundation (OPP49817).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The analyses were approved by the institutional review board of the University of California, Davis. All individual trial protocols were approved by appropriate institutional ethics committees.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData described in the manuscript, code book, and analytic code will not be made available because they are compiled from 14 different trials, and access is under the control of the investigators of each of those trials.ASQIAges and Stages Questionnaire InventoryBMIbody mass indexBSIDBayley Scales of Infant DevelopmentCDIMacArthur-Bates Communicative Development InventoryCMAMCommunity management of acute malnutritionDMCDevelopmental Milestones ChecklistEASQExtended Ages and Stages QuestionnaireHbhemoglobinIPDindividual participant dataKDIKilifi Developmental InventoryLAZlength-for-age z-scoreLMIClow- and middle-income countryLNSlipid-based nutrient supplementsMAMmoderate acute malnutritionMDATMalawi Developmental Assessment ToolMUACmid-upper arm circumferencePSEDProfile of Social and Emotional DevelopmentSDstandard deviationsSESsocio-economic statusSQ-LNSsmall-quantity lipid-based nutrient supplementsWASHwater, sanitation, and hygieneWLZweight-for-length z-score